Target intelligence / Profile preview

Low affinity immunoglobulin gamma Fc region receptor II-a (FCGR2A (also known as CD32a))

Target
FCGR2A (also known as CD32a)
Molecular classification
Receptor, Immunoglobulin superfamily, Cell surface receptor
01

Overview

Low affinity immunoglobulin gamma Fc region receptor II-a is a cell surface protein encoded by the FCGR2A gene. It is primarily expressed on phagocytic cells such as macrophages and neutrophils. This receptor binds the Fc portion of immunoglobulin G (IgG) antibodies with low affinity, mediating important immune functions including phagocytosis of opsonized pathogens, clearance of immune complexes, and initiation of inflammatory signaling pathways. By engaging IgG-coated targets, it promotes cellular responses against pathogens and soluble antigens. Genetic variations in FCGR2A are associated with altered susceptibility to autoimmune diseases such as systemic lupus erythematosus. The protein plays roles both in normal host defense mechanisms and pathological conditions involving inflammation or aberrant immune complex handling.

Other names
Fc gamma receptor IIaCD32aFcgammaRIIaFCGR2A
02

Mechanism of action

Drugs or therapeutic antibodies that engage this molecule typically act by binding to its extracellular domain via their IgG Fc region, triggering immune cell activation, phagocytosis, or cytotoxic responses against target cells coated with antibody.

03

Biological functions

Immune responsePhagocytosis of opsonized antigens and immune complexesAntibody-dependent cellular cytotoxicity (ADCC)Cell surface receptor signaling pathwayPositive regulation of tumor necrosis factor production
04

Disease associations

InflammationInfectionAutoimmune disease (e.g., systemic lupus erythematosus)Cancer (as a biomarker in colorectal cancer metastasis)
05

Safety considerations

Potential safety concerns include excessive immune activation leading to inflammation or tissue damagepolymorphisms can affect individual responses to antibody therapiespossible role in autoimmunity if dysregulated
06

Interacting drugs

There are no specific drugs directly targeting FCGR2A currently approved, but it is involved in the mechanism of action for therapeutic antibodies that rely on Fc-mediated effector functions such as ADCC and phagocytosis. Some monoclonal antibodies used in oncology and autoimmune diseases may interact functionally with this receptor through their IgG Fc regions.
07

Biomarkers

FCGR2A expression or genetic variants have been studied as biomarkers for susceptibility to autoimmune diseases like systemic lupus erythematosus and for predicting response to antibody-based therapies.It has also been identified as differentially expressed in metastatic colorectal cancer tissue, suggesting potential utility as a biomarker for cancer progression

Beyond the preview

Go deeper on Low affinity immunoglobulin gamma Fc region receptor II-a (FCGR2A (also known as CD32a)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Low affinity immunoglobulin gamma Fc region receptor II-a (FCGR2A (also known as CD32a)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call